ID: ALA3787398

Max Phase: Preclinical

Molecular Formula: C21H20N2O

Molecular Weight: 316.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc2ccccc2c1CNCCc1c[nH]c2ccccc12

Standard InChI:  InChI=1S/C21H20N2O/c24-21-10-9-15-5-1-2-6-17(15)19(21)14-22-12-11-16-13-23-20-8-4-3-7-18(16)20/h1-10,13,22-24H,11-12,14H2

Standard InChI Key:  WTJIBJOFWMMTGZ-UHFFFAOYSA-N

Associated Targets(non-human)

Transient receptor potential cation channel subfamily M member 8 202 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 316.40Molecular Weight (Monoisotopic): 316.1576AlogP: 4.36#Rotatable Bonds: 5
Polar Surface Area: 48.05Molecular Species: BASEHBA: 2HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.94CX Basic pKa: 10.99CX LogP: 3.16CX LogD: 2.57
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.48Np Likeness Score: -0.28

References

1. Bertamino A, Ostacolo C, Ambrosino P, Musella S, Di Sarno V, Ciaglia T, Soldovieri MV, Iraci N, Fernandez Carvajal A, de la Torre-Martinez R, Ferrer-Montiel A, Gonzalez Muniz R, Novellino E, Taglialatela M, Campiglia P, Gomez-Monterrey I..  (2016)  Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators.,  59  (5): [PMID:26847872] [10.1021/acs.jmedchem.5b01914]

Source